Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stratigos

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Dermatology Practical & Conceptual|May 6, 2021
Dermoscopy as a Tool in Differentiating Cutaneous Squamous Cell Carcinoma From Its VariantsDimitrios Sgouros, Melpomeni Theofili, Vasileia Damaskou, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 23, 2026
<i>Letter:</i> Nickel Sensitization After Patent Foramen Ovale ClosureAnastasios Apostolos, Maria Drakopoulou, Georgios Trantalis, et al.
Cancers|February 11, 2023
A Comprehensive Analysis of Cutaneous Melanoma Patients in Greece Based on Multi-Omic DataGeorgia Kontogianni, Konstantinos Voutetakis, Georgia Piroti, et al.
Archives of Dermatological Research|February 12, 2025
Long-term outcomes of upadacitinib in patients with prior dupilumab exposure: a case seriesStamatios Gregoriou, Ioannis-Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Dermatology and Therapy|January 15, 2025
Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre StudyStamatios Gregoriou, Ioannis-Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Dermatology and Therapy|March 6, 2026
Long-Term Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A Real-World, Retrospective StudyAikaterini Tsiogka, Ioannis-Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Journal of the American Academy of Dermatology|November 26, 2013
Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinomaAimilios Lallas, Thrassivoulos Tzellos, Athanasios Kyrgidis, et al.
Archives of Dermatology|May 23, 2007
Susceptibility to UV-A and UV-B provocation does not correlate with disease severity of polymorphic light eruptionArtiena Soe Janssens, Stan Pavel, Tsui Ling, et al.
Dermatology and Therapy|October 8, 2025
Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients with Psoriasis: An Observational StudyAikaterini Tsiogka, Stergios Soulaidopoulos, Stamatios Gregoriou, et al.
Journal of the American Academy of Dermatology|June 9, 2026
Response to Zou et al., " Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: a retrospective multicenter cohort study""Vasiliki Nikolaou, Ioannis-Alexios Koumprentziotis, Maria Gerochristou, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Dermatology Practical & Conceptual|May 6, 2021
Dermoscopy as a Tool in Differentiating Cutaneous Squamous Cell Carcinoma From Its VariantsDimitrios Sgouros, Melpomeni Theofili, Vasileia Damaskou, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 23, 2026
<i>Letter:</i> Nickel Sensitization After Patent Foramen Ovale ClosureAnastasios Apostolos, Maria Drakopoulou, Georgios Trantalis, et al.
Cancers|February 11, 2023
A Comprehensive Analysis of Cutaneous Melanoma Patients in Greece Based on Multi-Omic DataGeorgia Kontogianni, Konstantinos Voutetakis, Georgia Piroti, et al.
Archives of Dermatological Research|February 12, 2025
Long-term outcomes of upadacitinib in patients with prior dupilumab exposure: a case seriesStamatios Gregoriou, Ioannis-Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Dermatology and Therapy|January 15, 2025
Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre StudyStamatios Gregoriou, Ioannis-Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Dermatology and Therapy|March 6, 2026
Long-Term Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A Real-World, Retrospective StudyAikaterini Tsiogka, Ioannis-Alexios Koumprentziotis, Ileana Afroditi Kleidona, et al.
Journal of the American Academy of Dermatology|November 26, 2013
Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinomaAimilios Lallas, Thrassivoulos Tzellos, Athanasios Kyrgidis, et al.
Archives of Dermatology|May 23, 2007
Susceptibility to UV-A and UV-B provocation does not correlate with disease severity of polymorphic light eruptionArtiena Soe Janssens, Stan Pavel, Tsui Ling, et al.
Dermatology and Therapy|October 8, 2025
Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients with Psoriasis: An Observational StudyAikaterini Tsiogka, Stergios Soulaidopoulos, Stamatios Gregoriou, et al.
Journal of the American Academy of Dermatology|June 9, 2026
Response to Zou et al., " Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: a retrospective multicenter cohort study""Vasiliki Nikolaou, Ioannis-Alexios Koumprentziotis, Maria Gerochristou, et al.
Pageof 16